loader2
Partner With Us NRI

Aspira Pathlab & Diagnostics Ltd share Price Today

Company details

28.02
30.89
25.00
49.50
6M Return -22.15%
1Y Return 11.93%
Mkt Cap.(Cr) 31.39
Volume 100,868
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 100,868

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Aspira Pathlab & Diagnostics Ltd shares SWOT Analysis

Strengths (5)

  • Rising Net Cash Flow and Cash from Operating activity
  • Growth in Net Profit with increasing Profit Margin (QoQ)
  • Company with Low Debt

Weakness (6)

  • Negative profit growth, promoters decreasing shareholding QoQ
  • Inefficient use of capital to generate profits - RoCE declining in the last 2 years
  • Inefficient use of shareholder funds - ROE declining in the last 2 years

Opportunity (1)

  • Stock with Low PE (PE < = 10)

Threats (1)

  • Promoter decreasing their shareholding

Resistance and support

R1 31.3
R2 32.5
R3 34.1
Pivot

29.64

S1 28.4
S2 26.8
S3 25.5
EMA SMA
29.4
30.3
31.6
33.2
29.3
30.3
31.8
34.6
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
GLORIOUS HOLDINGS PVT LTD Bulk Sell 2024-06-28 30 75000 BSE
DEVJI DEYAT NANDA Bulk Purchase 2024-06-25 25.1 69009 BSE
GLORIOUS HOLDINGS PVT LTD Bulk Sell 2024-06-25 25.16 84000 BSE
Name Category Shares
ARVIND KARSANDAS BHANUSHALI PROMOTER 8.6%
DEEPALI ARVIND BHANUSHALI PROMOTER 8.6%
PARESH BHANJI BHANUSHALI PROMOTER 0.76%
RAJ ARVIND BHANUSHALI PROMOTER 0.76%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Aspira Pathlab & Diagnostics Ltd Stocks COMPARISON

Financials( in Cr) Aspira Pathlab & Diagnostics Ltd Max Healthcare Institute Ltd Apollo Hospitals Enterprise Ltd Fortis Healthcare Ltd Global Health Ltd
Price 30.50 940.65 6,185.70 475.35 1,308.30
% Change 4.34 2.16 -0.11 -0.62 2.54
Mcap Cr 31.39 91,422.90 88,941.09 35,886.93 35,128.77
Revenue TTM Cr 14.46 4,831.37 16,612.50 6,537.06 2,694.25
Net Profit TTM Cr -0.09 1,103.51 887.50 632.98 326.08
PE TTM 0.00 86.65 99.11 61.16 73.37
1 Year Return 11.93 55.92 20.65 55.83 99.44
ROCE 0.00 13.85 14.16 7.51 16.49
ROE 0.00 16.12 15.04 6.79 16.13
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 13.71 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 29,542.69 26,564.54
LAST 3M 107,300.08 -872.81
LAST 6M 187,950.75 839.71
LAST 12M 304,454.24 86,051.23

Aspira Pathlab & Diagnostics Ltd Information

Stock PE (TTM)
0
Promoter Holding
18.72%
Book Value
9.8543
ROCE
0%
ROE
0%
Description
  • Aspira Pathlab & Diagnostics Limited is a public limited company incorporated in July 03rd, 1973. The Company is engaged into the business of running, owning, managing and administering Diagnostics Centers. Its principal activities consist of pathology investigation services, radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai. During the year, the Company commenced its business activities of diagnostic center & pathology from November 2016 onwards by acquiring running business activities of `Ankur Pathology Laboratory`. The Company issued 2943000 equity shares of Rs. 10/- each at an issue price of Rs. 17/- per share (including share premium of Rs. 7/- per share) on preferential basis to promoters & group of strategic investors not forming part of the promoter. The allotment was made on 19th November 2016 & listing & trading approval is awaited. The paid-up capital as on 31st March 2017 was 5193000 equity shares of Rs. 10/- each. The Company has changed its object clause on 10th August 2016; its present name was changed on 16th November 2016 & registered office of the company was shifted from State of West Bengal to State of Maharashtra, vide order dated 18th November, 2016 & company again shifted its registered office within the city limit of Mumbai on 17th March, 2017. During the year 2017, the Company applied to BSE Limited on 27th July 2017 under Direct Listing norms of BSE Limited for listing & trading of its securities at BSE Limited. During the year 2018-19, issued, subscribed and paid- up capital of the of the Company has increased from 5,19,30,000 to Rs. 13,69,30,000/- divided into 81,93,000 Equity Shares of Rs. 10/- each and 55,00,000 9% Non-Cumulative, Non-convertible, Non-Participating Redeemable Preference Shares of Rs. 10/- each. The Company got delisting approval from Metropolitan Stock Exchange of India Limited and Calcutta Stock Exchange Limited w.e.f. April 12th, 2018 and October 15th , 2018 respectively.

Registered Address

Flat No. 2 RD Shah Building, Shraddanand Road Ghatkopar(W), Mumbai, Maharashtra, 400086

Tel : 91-22-71975756/5656
Email : info:aspiradiagnostics.com
Website : http://www.aspiradiagnostics.com
Registrar

Sharex Dynamic (India) Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 540788
NSE Code :
Book Closure Date (Month) : Sep
BSE Group : X
ISIN : INE500C01017

FAQ’s on Aspira Pathlab & Diagnostics Ltd Shares

You can buy Aspira Pathlab & Diagnostics Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Aspira Pathlab & Diagnostics Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jun 28, 2024 04:01 PM the closing price of Aspira Pathlab & Diagnostics Ltd was Rs.30.50.

The latest PE ratio of Aspira Pathlab & Diagnostics Ltd as of Jun 28, 2024 04:01 PM is 0.00

The latest PB ratio of Aspira Pathlab & Diagnostics Ltd as of Jun 28, 2024 04:01 PM is 0.32

The 52-week high of Aspira Pathlab & Diagnostics Ltd share price is Rs. 49.50 while the 52-week low is Rs. 25.00

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jun 28, 2024 04:01 PM, the market cap of Aspira Pathlab & Diagnostics Ltd stood at Rs. 31.39 Cr.

Download App

Download Our App

Play Store App Store
market app